13F filer · CIK 1600175
Opus Point Partners Management, LLC
New York, NY · filing since Q4 2014 · last filing Nov 14, 2019
Reported value
$55.3M
$-12.3M vs prior
Positions
55
New / sold out
2 / 10
Added / reduced
18 / 1
Turnover
2.6%
buys $1.6M · sells $5.6M
Top-10 weight
62.6%
Biggest buys vs Q2 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | FORTRESS BIOTECH INC | +379,521 | +162.2% | +$535.1K |
| New | UNITED THERAPEUTICS CORP DEL | +3,498 | – | +$279.0K |
| Added | AMARIN CORP PLC | +17,000 | +102.2% | +$257.7K |
| New | ALKERMES PLC | +11,632 | – | +$227.0K |
| Added | REGENERON PHARMACEUTICALS | +218 | +9.8% | +$60.5K |
| Added | DIREXION SHS ETF TR | +1,423 | +1.4% | +$44.0K |
| Added | FIBROGEN INC | +859 | +17.6% | +$31.7K |
| Added | LIGAND PHARMACEUTICALS INC | +317 | +15.0% | +$31.6K |
| Added | EXELIXIS INC | +1,692 | +14.8% | +$29.9K |
| Added | ALNYLAM PHARMACEUTICALS INC | +333 | +2.5% | +$26.8K |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q2 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | IMMUNOMEDICS INC | -62,575 | -100.0% | $-868.0K |
| Sold out | SAREPTA THERAPEUTICS INC | -5,353 | -100.0% | $-813.0K |
| Sold out | BLUEBIRD BIO INC | -5,840 | -100.0% | $-743.0K |
| Sold out | INSMED INC | -26,936 | -100.0% | $-690.0K |
| Sold out | PACIRA BIOSCIENCES | -11,250 | -100.0% | $-489.0K |
| Sold out | AMICUS THERAPEUTICS INC | -36,731 | -100.0% | $-458.0K |
| Sold out | VIKING THERAPEUTICS INC | -48,485 | -100.0% | $-402.0K |
| Sold out | MADRIGAL PHARMACEUTICALS INC | -3,570 | -100.0% | $-374.0K |
| Sold out | ANAPTYSBIO INC | -6,116 | -100.0% | $-345.0K |
| Sold out | AGIOS PHARMACEUTICALS INC | -4,806 | -100.0% | $-240.0K |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2019
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ISHARES TRNASDAQ BIOTECH | 125,000 | $12.4M | 22.48% |
| 2 | ISHARES TRCALLNASDAQ BIOTECH | 85,000 | $8.5M | 15.28% |
| 3 | DIREXION SHS ETF TRSP BIOTCH BL NEW | 99,855 | $3.1M | 5.58% |
| 4 | METTLER TOLEDO INTERNATIONALCOM | 3,235 | $2.3M | 4.12% |
| 5 | BRISTOL MYERS SQUIBB COCOM | 33,000 | $1.7M | 3.02% |
| 6 | SEATTLE GENETICS INCCOM | 18,020 | $1.5M | 2.78% |
| 7 | ILLUMINA INCCOM | 4,721 | $1.4M | 2.59% |
| 8 | VERTEX PHARMACEUTICALS INCCOM | 8,279 | $1.4M | 2.54% |
| 9 | IONIS PHARMACEUTICALS INCCOM | 20,124 | $1.2M | 2.18% |
| 10 | ALNYLAM PHARMACEUTICALS INCCOM | 13,684 | $1.1M | 1.99% |
45 more rows. Subscribe for $29/month to see every row, download the data and use the API.